Hence, it can be suggested that the downregulation of ABCG2 expression observed in colorectal cancer can result from inflammation in the bowel mucosa, and that this may represent a preliminary step in reducing its protective potential against cancer-promoting xenobiotics. Here, ABCG2 is linked to colorectal cancer.